Subunit Structure and Purification of Opioid Receptors

References

• Simon E. J., Hiller J. M., Edelman I. Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate, Proc. Natl. Acad. Sci. USA 1973; 70: 1947–1949
   PubMed Web of Science ®Google Scholar
• Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex, Acta. Pharmacol. Toxicol. 1973; 32: 317–329
   Google Scholar
• Pert C. B., Snyder S. H. Opiate receptor: Demonstration in nervous tissue. Science 1973; 179: 1011–1014
   PubMed Web of Science ®Google Scholar
• Hiller J. M., Pearson J., Simon E. J. Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system, Res. Commun. Chem. Pathol. Pharmacol. 1973; 6: 1052–1062
   PubMedGoogle Scholar
• Stefano G. B., Kream R. M., Zukin R. S. Demonstration of stereospecific opiate binding in the nervous tissue of the marine mollusc Mytilus edulis. Brain Res. 1980; 180: 440–445
   Google Scholar
• Kuhar M. J., Pert C. B., Snyder S. H. Regional distribution of opiate receptor binding in monkey and human brain. Nature 1973; 245: 447–450
   PubMed Web of Science ®Google Scholar
• Atweh S. F., Kuhar M. J. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla, Brain Res. 1977; 124: 53–67
   Google Scholar
• Atweh S. F., Kuhar M. J. Autoradiographic localization of opiate receptors in rat brain. II. The brainstem, Brain Res. 1977; 129: 1–12
   PubMed Web of Science ®Google Scholar
• Atweh S. F., Kuhar M. J. Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon, Brain Res. 1977; 134: 393–406
   PubMed Web of Science ®Google Scholar
• Pearson J., Brandeis L., Simon E., Hiller J. Radioautography of binding of tritiated diprenorphine to opiate receptors in the rat, Life. Sci. 1980; 26: 1047–1052
   Google Scholar
• Creese I., Snyder S. H. Receptor binding and pharmacological activity of opiates in the guinea-pig intestine. J. Pharmacol. Exp. Ther. 1975; 194: 205–219
   PubMed Web of Science ®Google Scholar
• Stahl K. D., Van Bever W., Janssen P., Simon E. J. Receptor affinity and pharmacological potency of a series of narcotic analgesic, antidiarrheal and neuroleptic drugs, Eur. J. Pharmacol. 1977; 46: 199–205
   Google Scholar
• Terenius L., Wahlstrom A. Inhibitor(s) of narcotic receptor binding in brain extracts and cerebrospinal fluid, Acta Pharmacol. Toxicol. 35; Suppl. 1974; 1: 55
   Google Scholar
• Hughes J. Isolation of an endogenous compound from the brain with properties similar to morphine. Brain Res. 1975; 88: 295–308
   PubMed Web of Science ®Google Scholar
• Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975; 258: 577–579
   PubMed Web of Science ®Google Scholar
• Cox B. M., Goldstein A., Li C. H. Opioid activity of a peptide, beta-lipotropin-(61–91), derived from beta-lipotropin, Proc. Natl. Acad. Sci. USA 1976; 73: 1821–1823
   PubMed Web of Science ®Google Scholar
• Goldstein A, Tachibana S., Lowney L., Hunkapiller M., Hood L. Dynorphin (1–13), an extraordinarily potent opioid peptide, Proc. Natl. Acad. Sci. USA 1979; 76: 6666–6670
   PubMed Web of Science ®Google Scholar
• Goldstein A., Fischli W., Lowney L. I., Hunkapiller M., Hood L. Porcine pituitary dynorphin: Complete amino acid sequence of biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA 1981; 78: 7219–7223
   PubMed Web of Science ®Google Scholar
• Portoghese P. S. A new concept on the mode of interaction of narcotic analgesics with receptors. J. Med. Chem. 1965; 8: 609–619
   PubMed Web of Science ®Google Scholar
• Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exptl. Ther. 1976; 197: 517–532
   PubMed Web of Science ®Google Scholar
• Gilbert P. E., Martin W. R. The effects of morphin- and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976; 198: 66–82
   PubMed Web of Science ®Google Scholar
• Lord J. A.H., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature 1997; 267: 495–499
   Google Scholar
• Simon E. J., Hiller J. M. Opioids - Past, Present and Future, J. Hughes, H. O.J. Collier, M. J. Rance, M. B. Tyers. Taylor and Francis, London 1984; 33–52
   Google Scholar
• Oka K., Kantrowitz J. D., Spector S. Isolation of morphine from toad skin, Proc. Natl. Acad. Sci. USA 1985; 82: 1852–1854
   PubMed Web of Science ®Google Scholar
• Goldstein A, Barrett R. W., James I. F., Lowney L. I., Weitz C. J., Knipmeyer L. L., Rapoport H. Morphine and other opiates from beef brain and adrenal, Proc. Natl. Acad. Sci. USA 1985; 72: 5203–5207
   Google Scholar
• Donnerer J., Oka K., Brossi A., Rice K. C., Spector S. Presence and formation of codeine and morphine in the rat, Proc. Natl. Acad. Sci. USA 1986; 83: 4566–4567
   PubMed Web of Science ®Google Scholar
• Vincent J. P., Kartalovski B., Geneste P., Kamenko J. M., Lazdunski M. Interaction of phencyclidine (“angel dust”) with a specific receptor in rat brain membranes, Proc. Natl. Acad. Sci. USA 1979; 76: 4678–4682
   PubMed Web of Science ®Google Scholar
• Zukin S. R., Zukin R. S. Specific [3H]phencyclidine binding in rat central nervous system, Proc. Natl. Acad. Sci. USA 1979; 76: 5372–5376
   PubMed Web of Science ®Google Scholar
• Simon E. J., Hiller J. M, Edelman I. Solubilization of a stereospecific opiate-macromolecular complex from rat brain. Science 1975; 190: 389–390
   PubMed Web of Science ®Google Scholar
• Ruegg U. T., Hiller J. M., Simon E. J. Solubilization of an active opiate receptor from Bufo marinus, Eur. J. Pharmacol. 1980; 64: 367–368
   Google Scholar
• Ruegg U. T., Cuenod S., Hiller J. M., Gioannini T., Howells R. D., Simon E. J. Characterization and partial purification of solubilized active opiate receptors from toad brain, Proc. Natl. Acad. Sci. USA 1981; 78: 4635–4638
   PubMed Web of Science ®Google Scholar
• Howells R. D., Gioannini T. L., Hiller J. M., Simon E. J. Solubilization and characterization of active opiate binding sites from mammalian brain. J. Pharmacol. Exp. Ther. 1982; 222: 629–634
   PubMed Web of Science ®Google Scholar
• Bidlack J. M., Abood L. G. Solubilization of the opiate receptor. Life Sci. 1980; 27: 331–340
   PubMed Web of Science ®Google Scholar
• Simonds W. F., Koski G., Streaty R. A., Hjelmeland L. M., Klee W. A. Solubilization of active opiate receptors, Proc. Natl. Acad. Sci. USA 1980; 77: 4623–4627
   PubMed Web of Science ®Google Scholar
• Cho T. M., Yamato C., Cho J. S., Loh H. H. Solubilization of membrane bound opiate receptors from rat brain. Life Sci. 1981; 28: 2651–2657
   PubMed Web of Science ®Google Scholar
• Demoliou-Mason C., Barnard E. A. Solubilization in high yield of opioid receptors retaining high-affinity delta. mu and kappa binding sites, FEBS Lett. 1984; 170: 378–382
   PubMed Web of Science ®Google Scholar
• Gioannini T, Foucaud B., Hiller J. M., Hatten M. E., Simon E. J. Lectin binding of solubilized opiate receptors: Evidence for their glycoprotein nature, Biochem. Biophys. Res. Commun. 1982; 105: 1128–1134
   PubMed Web of Science ®Google Scholar
• Itzhak Y, Hiller J. M., Simon E. J. Solubilization and characterization of mu, delta and kappa opioid binding sites from guinea pig brain: Physical separation of kappa receptors, Proc. Natl. Acad. Sci. USA 1984; 81: 4217–4221
   PubMed Web of Science ®Google Scholar
• Robson L. E., Foote R. W., Maurer R., Kosterlitz H. W. Opioid binding sites of the kappa-type in guinea pig cerebellum. Neuroscience 1984; 12: 621–627
   PubMed Web of Science ®Google Scholar
• Chow T., Zukin R. S. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain, Mol. Pharmacol. 1983; 24: 203–212
   Web of Science ®Google Scholar
• Howard A. D., De La Baume S., Gioannini T. L., Hiller J. M., Simon E. J. Covalent labeling of opioid receptors with radioiodinated human beta-endorphin. J. Biol. Chem. 1985; 260: 10833–10839
   PubMed Web of Science ®Google Scholar
• Howard A. D., Sarne Y., Gioannini T. L., Hiller J. M., Simon E. J. Identification of distinct binding site subunits of mu and delta opioid receptors. Biochemistry 1986; 25: 357–360
   PubMed Web of Science ®Google Scholar
• Simonds W. F., Burke T. R., Jr., Rice K. C., Jacobson A. E., Klee W. A. Purification of the opiate receptor of NG108–15 neuroblastoma-glioma hybrid cells, Proc. Natl. Acad. Sci. USA 1985; 82: 4974–4978
   PubMed Web of Science ®Google Scholar
• Bidlack J. M., Abood L. G., Osei-Gyimah P., Archer S. Purification of the opiate receptor from rat brain, Proc. Natl. Acad. Sci. USA 1981; 78: 636–639
   PubMed Web of Science ®Google Scholar
• Maneckjee R., Zukin R. S., Archer S., Michael J., Osei-Gyimah P. Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography, Proc. Natl. Acad. Sci. USA 1985; 82: 594–598
   PubMed Web of Science ®Google Scholar
• Cho T. M., Hasegawa J-I., Ge B-L., Loh H. H. Purification to apparent homogeneity of a mu-type opioid receptor from rat brain, Proc. Natl. Acad. Sci. USA 1986; 83: 4138–4142
   PubMed Web of Science ®Google Scholar
• Barnard E. A., personal communication
   Google Scholar
• Gioannini T. L., Howard A. D., Hiller J. M., Simon E. J. Purification of an active opioid-binding protein from bovine striatum. J. Biol. Chem. 1985; 260: 15117–15121
   PubMedGoogle Scholar
• Gioannini T. L., Howard A., Hiller J. M., Simon E. J. Affinity chromatography of solubilized opioid binding sites using CH-Sepharose modified with a new naltrexone derivative, Biochem. Biophys. Res. Commu. 1984; 119: 624–629
   PubMed Web of Science ®Google Scholar